To further examine the feasibility of SPG20 methylation, as a noninvasive methylation biomarker for the early detection of gastric cancer, we performed conventional methylation-specific PCR to amplify short fragment of methylated DNA from cell-free DNA (cfDNA) obtained from serum samples of non-cancer individuals, and patients with IM or gastric cancer. The gene discussed is SPART; the disease is cancer.